| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Provision for income taxes | 0 | 0 | 0 | - |
| Total revenue-Product | 0 | 0 | 0 | - |
| Total revenue-Consulting Fees | 0 | 0 | 0 | - |
| Total revenue | 0 | 0 | 0 | - |
| Cost of product sales | 0 | 0 | 0 | - |
| Gross profit (loss) | 0 | 0 | 0 | - |
| Amortization of right of first refusal agreement cost | 0 | 0 | 417 | 1,250 |
| Stock-based compensation | - | - | 1,800 | - |
| Officers compensation | 30,000 | 30,000 | 30,000 | 30,000 |
| Other operating expenses | 7,412 | 18,251 | 11,319 | 9,193 |
| Total operating expenses | 37,412 | 48,251 | 43,536 | 40,443 |
| Income (loss) from operations | -37,412 | -48,251 | -43,536 | -40,443 |
| Interest expense | - | 885 | 2,055 | 5,722 |
| Note default penalties and interest | - | 167,417 | 138,906 | - |
| Loss on conversion of notes payable | - | 174,300 | 57,920 | - |
| Interest expense | 1,313 | - | - | - |
| Total other income (expenses) | 1,313 | -342,602 | -198,881 | -5,722 |
| Income (loss) before provision for income taxes | -36,099 | -390,853 | -242,417 | -46,165 |
| Net loss | -36,099 | -390,853 | -242,417 | -46,165 |
| Basic income (loss) per common share | -0.04 | 0 | 0 | 0 |
| Diluted income (loss) per common share | -0.04 | 0 | 0 | 0 |
| Weighted average common shares outstanding-basic | 900,256 | 1,286,797,269 | 910,373,303 | 804,638,436 |
| Weighted average common shares outstanding-diluted | 900,256 | 1,286,797,269 | 910,373,303 | 804,638,436 |
Greater Cannabis Company, Inc. (GCAN)
Greater Cannabis Company, Inc. (GCAN)